Generis is a UK-headquartered developer of world-class Content and Regulatory Information Management technology for regulated industries globally.

​

Eight of the top 10 global life sciences companies rely on Generis’ flagship Intelligent Content Services platform, CARA™ for critical document and information management, including AbbVie, AstraZeneca, Biogen, Gilead, Bayer, Pfizer, and Merck KGaA.

 

Today Generis serves more than half a million users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com.

 

About CARA:  

CARA is the world’s first enterprise workspace designed specifically for regulated industries, offering a simple, unified way of working with business-critical content and information. The platform delivers secure, versatile, and scalable solutions both in the cloud or on premise, alleviating the need for investment in multiple siloed solutions.